AERIE PHARMACEUTICALS INC·4

Sep 22, 5:40 PM ET

MCGRAW BENJAMIN F III 4

4 · AERIE PHARMACEUTICALS INC · Filed Sep 22, 2021

Insider Transaction Report

Form 4
Period: 2021-09-20
Transactions
  • Award

    Stock Option (right to buy)

    2021-09-20+102,412102,412 total
    Exercise: $11.59Exp: 2031-09-20Common Stock (102,412 underlying)
  • Award

    Common Stock

    2021-09-20+34,51346,063 total
Footnotes (2)
  • [F1]Subject to the reporting person's continued service as Interim Executive Chair through the vesting date, these shares of Common Stock are scheduled to vest on the earliest of (i) March 17, 2021 and (ii) the date on which the reporting person's service as Interim Executive Chair ceases following the company's appointment of a new CEO.
  • [F2]Subject to the reporting person's continued service as Interim Executive Chair through the vesting date, this option is scheduled to vest on the earliest of (i) March 17, 2021 and (ii) the date on which the reporting person's service as Interim Executive Chair ceases following the company's appointment of a new CEO.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION